Final data from ORIGIN and VISIONARY trials pave way for full FDA approvals ...

Oct 22 (Reuters) - US biotech company Vor Bio said on Thursday its experimental kidney disease drug slowed the loss of kidney ...

The phase 2 BESTOW clinical trial showed that tegoprubart (a novel anti-CD40L antibody therapy) was better at preserving ...

An exploratory analysis of the KiTS23 dataset found that a CT-derived tumor burden ratio was associated with a modestly ...

GLP-1 receptor agonists reduce albuminuria and slow kidney function decline, with the strongest clinical evidence supporting ...

The Phase 2 BESTOW clinical trial showed that tegoprubart (a novel anti-CD40L antibody therapy) was better at preserving ...

An exploratory genomic framework combining Mendelian randomization, kidney-compartment eQTL data, and colocalization ...

A mismatch between two common tests for kidney function may indicate a higher risk for kidney failure, heart disease, and death, a new study shows. Health care providers for decades have measured ...

Some drinks are better for your kidneys than others, especially in the morning. However, one drink in particular is ...

A new study found an association between hydroxychloroquine (HCQ) use and early and long-term benefits on kidney function in people with lupus nephritis, (LN, lupus-related kidney disease). HCQ (known ...

Explore-CKD met its primary endpoint; lorundrostat 25 mg once daily added to an SGLT2 inhibitor achieved a statistically significant reduction ...

Heart failure patients treated with finerenone (Kerendia; Bayer AG) are more likely to have an early decline in kidney function than those treated with placebo, but the decline should not be construed ...